Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease

被引:6
|
作者
Sarkar, Alika [1 ,2 ]
Rasheed, Mohd Sami Ur [1 ,2 ]
Singh, Mahendra Pratap [1 ,2 ]
机构
[1] CSIR Indian Inst Toxicol Res CSIR IITR, Toxicogen & Predict Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India
[2] Acad Sci & Innovat Res AcSIR, Ghaziabad, India
关键词
PD; redox modulation; mitochondrial protein; neurotoxicant; oxidative stress; COMPLEX-I INHIBITION; TARGETED ANTIOXIDANT MITOQ; CYSTEINE-SULFINIC ACID; MPTP MOUSE MODEL; OXIDATIVE STRESS; SUBSTANTIA-NIGRA; S-NITROSYLATION; DOPAMINERGIC-NEURONS; CELL-DEATH; INCREASED SUSCEPTIBILITY;
D O I
10.1089/ars.2022.0106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Mitochondrial proteins regulate the oxidative phosphorylation, cellular metabolism, and free radical generation. Redox modulation alters the mitochondrial proteins and instigates the damage to dopaminergic neurons. Toxicants contribute to Parkinson's disease (PD) pathogenesis in conjunction with aging and genetic factors. While oxidative modulation of a number of mitochondrial proteins is linked to xenobiotic exposure, little is known about its role in the toxicant-induced PD. Understanding the role of redox modulation of mitochondrial proteins in complex cellular events leading to neurodegeneration is highly relevant.Recent Advances: Many toxicants are shown to inhibit complex I or III and elicit free radical production that alters the redox status of mitochondrial proteins. Implication of redox modulation of the mitochondrial proteins makes them a target to comprehend the underlying mechanism of toxicant-induced PD.Critical Issues: Owing to multifactorial etiology, exploration of onset and progression and treatment outcomes needs a comprehensive approach. The article explains about a few mitochondrial proteins that undergo redox changes along with the promising strategies, which help to alleviate the toxicant-induced redox imbalance leading to neurodegeneration.Future Directions: Although mitochondrial proteins are linked to PD, their role in toxicant-induced parkinsonism is not yet completely known. Preservation of antioxidant defense machinery could alleviate the redox modulation of mitochondrial proteins. Targeted antioxidant delivery, use of metal chelators, and activation of nuclear factor erythroid 2-related factor 2, and combinational therapy that encounters multiple free radicals, could ameliorate the redox modulation of mitochondrial proteins and thereby PD progression.
引用
收藏
页码:824 / 852
页数:29
相关论文
共 50 条
  • [1] Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease
    Trancikova, Alzbeta
    Tsika, Elpida
    Moore, Darren J.
    ANTIOXIDANTS & REDOX SIGNALING, 2012, 16 (09) : 896 - 919
  • [2] Mitochondrial dysfunction, iron accumulation, and ferroptosis in Parkinson's disease
    Teferi, Nahom
    Challa, Meron
    Woodiwiss, Timothy
    Allen, Bryan
    Petronek, Michael
    REDOX EXPERIMENTAL MEDICINE, 2023, 2023 (01):
  • [3] Modulation of cellular redox environment as a novel therapeutic strategy for Parkinson's disease
    Deus, Claudia M.
    Teixeira, Jose
    Raimundo, Nuno
    Tucci, Paolo
    Borges, Fernanda
    Saso, Luciano
    Oliveira, Paulo J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (10)
  • [4] Toxin Models of Mitochondrial Dysfunction in Parkinson's Disease
    Martinez, Terina N.
    Greenamyre, J. Timothy
    ANTIOXIDANTS & REDOX SIGNALING, 2012, 16 (09) : 920 - 934
  • [5] Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease
    Lopert, Pamela
    Patel, Manisha
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (02) : 113 - 123
  • [6] Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection
    Mukherjee, Uma A.
    Ong, Sang-Bing
    Ong, Sang-Ging
    Hausenloy, Derek J.
    PHARMACOLOGY & THERAPEUTICS, 2015, 156 : 34 - 43
  • [7] Reinforcing mitochondrial functions in aging brain: An insight into Parkinson's disease therapeutics
    Chandra, G.
    Shenoi, R. A.
    Anand, R.
    Rajamma, U.
    Mohanakumar, K. P.
    JOURNAL OF CHEMICAL NEUROANATOMY, 2019, 95 : 29 - 42
  • [8] Mitochondrial Dysfunction in Parkinson's Disease
    Zhu, Jianhui
    Chu, Charleen T.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 : S325 - S334
  • [9] Mitochondrial Dysfunction in Parkinson's Disease
    Keane, P. C.
    Kurzawa, M.
    Blain, P. G.
    Morris, C. M.
    PARKINSONS DISEASE, 2011, 2011
  • [10] Mitochondrial Biology and Parkinson's Disease
    Perier, Celine
    Vila, Miquel
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (02):